I. Introduction
Drug delivery through micromachined needles is of great interest to transport therapeutic agents, virus-like-particles, and other molecules into the body through the skin with minimal invasiveness and pain. Drug delivery with microneedles (MNs) has been shown to induce immune responses or biological effects that are comparable to those induced by a hypodermic needle (HN) injection in animal studies with influenza, Hepatitis B, Hepatitis C, and diabetes. [1]–[3] In addition, one human study with influenza reported that the influenza vaccines delivered with MNs produced immune responses similar to those from an HN vaccination. [4]